Vol 10, Supp. A (2019)
Case report
Published online: 2019-04-26

open access

Page views 437
Article views/downloads 296
Get Citation

Connect on Social Media

Connect on Social Media

The effectiveness of ruxolitinib in a patient with primary myelofibrosis

Agata Obara1, Marcin Pasiarski1

Abstract

Primary myelofibrosis belongs to chronic myeloproliferative neoplasms BCR-ABL1-negative. In this article, we present a case of 74 years-old woman, treated with hydroxyurea at the beginning of the diagnosis. Subsequently, ruxolitinib therapy was started.

Article available in PDF format

View PDF (Polish) Download PDF file



Hematology in Clinical Practice